Domov › Rak dojke › Connecticut › Bridgeport
Klinične študije za Rak dojke v Bridgeport, CT
21 študij za Rak dojke išče udeležence na lokacijah v Bridgeport in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Stony Brook University Medical Center, Stony Brook · 18 mi stran
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Vključevanje udeležencevFaza 3
- Stony Brook University-Cancer Center ( Site 0034), Stony Brook · 18 mi stran
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Vključevanje udeležencevFaza 3
- Research Site, Stony Brook · 18 mi stran
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Vključevanje udeležencevFaza 3
- Smilow Cancer Hospital Care Center - Trumbull, Trumbull · 4 mi stran
- Smilow Cancer Hospital Care Center - Fairfield, Fairfield · 5 mi stran
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Vključevanje udeležencev
- Stony Brook Cancer Center, Stony Brook · 18 mi stran
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Vključevanje udeležencevFaza 1/2
- Stony Brook University Hospital, Stony Brook · 18 mi stran
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Vključevanje udeležencevFaza 3
- Stony Brook University Medical Center, Stony Brook · 18 mi stran
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Vključevanje udeležencevFaza 3
- Stony Brook University Cancer Center, Stony Brook · 18 mi stran
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Vključevanje udeležencevFaza 3
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C. (Port Jefferson Station2), Port Jefferson Station · 19 mi stran
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C.(Port Jefferson Station1), Port Jefferson Station · 19 mi stran
- New York Cancers & Blood Specialists, Port Jefferson Station · 19 mi stran
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Vključevanje udeležencevFaza 3
- Hartford HealthCare - Saint Vincent's Medical Center, Bridgeport
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mi stran
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 mi stran
- in še 1
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Vključevanje udeležencevFaza 2
- Stony Brook Cancer Center, Stony Brook · 18 mi stran
ATEMPT 2.0: Adjuvant T-DM1 vs TH
Vključevanje udeležencevFaza 2
- Smilow Cancer Hospital Care center at Trumbull, Trumbull · 4 mi stran
- Smilow Cancer Hospital Care center at Fairfield, Fairfield · 5 mi stran
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Vključevanje udeležencevFaza 1
- New York Cancer and Blood Specialists, Port Jefferson Station · 19 mi stran
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Vključevanje udeležencevFaza 3
- Stony Brook University Cancer Center, Stony Brook · 18 mi stran
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Vključevanje udeležencevFaza 3
- Smilow Cancer Hospital - Fairfield, Fairfield · 5 mi stran
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Vključevanje udeležencevFaza 3
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mi stran
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 mi stran
- Stony Brook University Medical Center, Stony Brook · 18 mi stran
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Vključevanje udeležencevOpazovalna študija
- Stony Brook Medicine, Stony Brook · 18 mi stran
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
Vključevanje udeležencevZgodnja faza 1
- Stony Brook Breast Center, Stony Brook · 18 mi stran
Definitive Radiation Therapy for Inoperable Breast Cancer
Vključevanje udeležencev
- Stony Brook University Cancer Center, Stony Brook · 18 mi stran
Definitive Radiation for High-Risk Spine Metastases
Vključevanje udeležencevFaza 2
- Stony Brook University Hospital, Stony Brook · 18 mi stran
CtDNA Based MRD Testing for NAC Monitoring in TNBC
Vključevanje udeležencevOpazovalna študija
- Stony Brook University Cancer Center, Stony Brook · 18 mi stran
Študije za Rak dojke v drugih mestih
- New York City, NY136 študij
- Houston, TX126 študij
- Boston, MA112 študij
- Nashville, TN81 študij
- Los Angeles, CA73 študij
- Edison, NJ68 študij
- St. Louis, MO64 študij
- Queens, NY64 študij
- Durham, NC64 študij
- Chicago, IL59 študij
- Philadelphia, PA56 študij
- Dallas, TX55 študij
Druge študije v Bridgeport
- Nemalicelični pljučni rak14 študij
- Rak pljuč13 študij
- Akutna mieločna levkemija12 študij
- Srčno-žilne bolezni9 študij
- Rak (vse vrste)8 študij
- Ploščatocelični karcinom glave in vratu8 študij
- Metastatski rak7 študij
- Srčno popuščanje7 študij
- Možganska anevrizma6 študij
- Množni mielom6 študij
- Rak prostate6 študij
- Rak jajčnikov5 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.